title: Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice.
abstract: High fat feeding induces a variety of obese and lean phenotypes in inbred rodents. Compared to Diet Resistant (DR) rodents, Diet Induced Obese (DIO) rodents are insulin resistant and have a reduced dopamine receptor D2 (DRD2) mediated tone. We hypothesized that this differing dopaminergic tone contributes to the distinct metabolic profiles of these animals. C57Bl6 mice were classified as DIO or DR based on their weight gain during 10 weeks of high fat feeding. Subsequently DIO mice were treated with the DRD2 agonist bromocriptine and DR mice with the DRD2 antagonist haloperidol for 2 weeks. Compared to DR mice, the bodyweight of DIO mice was higher and their insulin sensitivity decreased. Haloperidol treatment reduced the voluntary activity and energy expenditure of DR mice and induced insulin resistance in these mice. Conversely, bromocriptine treatment tended to reduce bodyweight and voluntary activity, and reinforce insulin action in DIO mice. These results show that DRD2 activation partly redirects high fat diet induced metabolic anomalies in obesity-prone mice. Conversely, blocking DRD2 induces an adverse metabolic profile in mice that are inherently resistant to the deleterious effects of high fat food. This suggests that dopaminergic neurotransmission is involved in the control of metabolic phenotype.
authors: Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, RC Leiden, The Netherlands.
authors: J E
authors: JE
authors: de Leeuw van Weenen
authors: E T
authors: ET
authors: Parlevliet
authors: J P
authors: JP
authors: Schröder-van der Elst
authors: S A
authors: SA
authors: van den Berg
authors: K
authors: K
authors: Willems van Dijk
authors: J A
authors: JA
authors: Romijn
authors: H
authors: H
authors: Pijl
references: Nature. 2005 Apr 21;434(7036):1026-31
references: 15846348
references: Cell. 1995 Dec 29;83(7):1197-209
references: 8548806
references: Brain Res. 2002 Jun 7;939(1-2):95-9
references: 12020855
references: Cell. 1994 Dec 16;79(6):923-6
references: 8001139
references: Horm Metab Res. 1982 Feb;14(2):57-61
references: 7040191
references: Endocrinology. 2005 Feb;146(2):901-12
references: 15550506
references: Mov Disord. 2006 Apr;21(4):524-9
references: 16261618
references: Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R981-6
references: 15604298
references: Int J Obes (Lond). 2007 Aug;31(8):1210-21
references: 17471301
references: Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1038-43
references: 16803851
references: Horm Metab Res. 1985 Apr;17(4):220-1
references: 4007774
references: Rev Diabet Stud. 2007 Fall;4(3):185-94
references: 18084676
references: Behav Brain Res. 2006 Dec 15;175(2):415-9
references: 17000016
references: J Biomed Sci. 2002 Mar-Apr;9(2):126-32
references: 11914579
references: Diabetes. 2004 Oct;53(10):2529-34
references: 15448080
references: J Clin Psychopharmacol. 2008 Jun;28(3):289-95
references: 18480685
references: Metabolism. 1995 Oct;44(10):1349-55
references: 7476296
references: Nutrition. 2000 Oct;16(10):843-57
references: 11054589
references: J Clin Epidemiol. 2003 Feb;56(2):164-70
references: 12654411
references: Pharmacol Res. 2008 Sep-Oct;58(3-4):240-6
references: 18790058
references: Am J Physiol. 1997 May;272(5 Pt 2):R1365-70
references: 9176325
references: J Pharmacol Exp Ther. 1987 Dec;243(3):1159-66
references: 2826757
references: Am J Physiol Regul Integr Comp Physiol. 2002 Oct;283(4):R905-10
references: 12228060
references: Neuropharmacology. 2003 Jun;44(7):882-92
references: 12726820
references: Endocrinology. 2003 Aug;144(8):3399-405
references: 12865318
references: Brain Res Mol Brain Res. 2003 Jul 4;115(1):21-8
references: 12824051
references: Eur Neuropsychopharmacol. 2000 May;10(3):159-64
references: 10793317
references: Neuroendocrinology. 1999 Mar;69(3):160-6
references: 10087448
references: J Pharmacol Exp Ther. 2002 Nov;303(2):791-804
references: 12388666
references: Life Sci. 1997;61(10):951-6
references: 9296333
references: Ann Intern Med. 1996 Jan 1;124(1 Pt 2):97-103
references: 8554221
references: Endocrinology. 1999 Jul;140(7):3197-202
references: 10385415
references: Diabetologia. 2006 Apr;49(4):732-8
references: 16485139
references: Lancet. 2001 Feb 3;357(9253):354-7
references: 11210998
references: Am J Psychiatry. 1999 Nov;156(11):1686-96
references: 10553730
references: Diabetes. 1994 Feb;43(2):173-9
references: 8288040
references: Clinics (Sao Paulo). 2010;65(9):885-94
references: 21049217
references: CNS Drugs. 2005;19 Suppl 1:1-93
references: 15998156
references: Eur J Endocrinol. 2003 Oct;149(4):343-50
references: 14514350
references: Int J Obes Relat Metab Disord. 1999 Apr;23(4):425-31
references: 10340822
references: J Biol Chem. 2004 Jan 9;279(2):1108-15
references: 14581480
references: Neuroendocrinology. 1998 Jul;68(1):1-10
references: 9695933
references: J Clin Endocrinol Metab. 1983 Mar;56(3):595-602
references: 6822657
references: Neuroendocrinology. 1996 Mar;63(3):269-74
references: 8677015
references: Pharmacol Biochem Behav. 1987 Jul;27(3):399-405
references: 2889218
references: Metabolism. 1988 Aug;37(8):802-6
references: 3043146
references: Eur J Endocrinol. 2003 Sep;149(3):187-93
references: 12943520
references: Diabetologia. 2000 Jul;43(7):899-906
references: 10952463
references: Eur J Pharmacol. 2003 Nov 7;480(1-3):125-31
references: 14623356
references: Am J Physiol. 1989 Sep;257(3 Pt 1):E439-43
references: 2571300
references: Int J Obes Relat Metab Disord. 1998 Oct;22(10):993-9
references: 9806315
references: Endocrinology. 2010 Apr;151(4):1441-50
references: 20147524
references: Eur Neuropsychopharmacol. 2001 Oct;11(5):327-32
references: 11597818
references: J Clin Endocrinol Metab. 2006 Aug;91(8):3236-40
references: 16705078
references: Diabetes Care. 2000 Aug;23(8):1154-61
references: 10937514
references: Clin Investig. 1993 May;71(5):372-8
references: 8508007
references: Diabetes. 2005 Mar;54(3):862-71
references: 15734866
references: Diabetes. 2009 Dec;58(12):2749-56
references: 19720789
references: Biochem Pharmacol. 2010 Jun 15;79(12):1827-36
references: 20138024
references: Endocrinology. 1993 Aug;133(2):705-12
references: 8344209
references: J Neuroendocrinol. 2008 Jan;20(1):120-7
references: 18081560
references: Obesity (Silver Spring). 2011 Apr;19(4):800-5
references: 20559294
references: Eur J Pharmacol. 2001 Aug 17;425(3):197-201
references: 11513838
references: Brain Res Bull. 1986 Mar;16(3):331-9
references: 3708389
references: Expert Rev Mol Med. 2007 Feb 22;9(5):1-24
references: 17316471
references: Obes Res. 2004 Apr;12(4):612-20
references: 15090628
references: J Pharmacol Exp Ther. 1998 Aug;286(2):607-10
references: 9694910
references: Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E834-42
references: 11882503
references: Expert Opin Investig Drugs. 1999 Oct;8(10):1683-1707
references: 11139820
references: Am J Psychiatry. 1999 Feb;156(2):312-4
references: 9989571
references: Eur J Pharmacol. 1988 Jun 10;150(3):361-6
references: 2970974
references: J Clin Endocrinol Metab. 1980 Aug;51(2):242-6
references: 6995475
references: Brain Res. 2002 Dec 6;957(1):144-51
references: 12443990
references: Neuroreport. 1995 May 30;6(8):1191-4
references: 7662905
references: Pituitary. 2009;12(4):330-4
references: 19408128
references: Am J Physiol. 1990 Dec;259(6 Pt 2):R1103-10
references: 2260721
references: Physiol Behav. 1995 Jun;57(6):1103-6
references: 7544469
references: Diabetes. 2001 Nov;50(11):2585-90
references: 11679438
references: Arch Neurol. 2010 May;67(5):589-95
references: 20457959